Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ShareHope Medicine CoROCO:8403 70 PE Ratio (TTM) is 20.16 as of Aug. 02, 2026, which is 3% below its 10-year median of 20.88. GuruFocus rates ROCO:8403 with a GF Score™ of 70/100 and a GF Value™ of NT$29.89 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 87 Medical Distribution companies, ShareHope Medicine Co ranks worse than 65.52% on this metric.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-08-02), ShareHope Medicine Co's share price is
NT$18.95.
ShareHope Medicine Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was NT$0.94. Therefore, ShareHope Medicine Co's PE Ratio (TTM) for today is 20.16.
The historical rank and industry rank for ShareHope Medicine Co's PE Ratio (TTM) or its related term are showing as below:
ROCO:8403'
s PE Ratio (TTM) Range Over the Past 10 Years
Min: 8.11 Med: 20.88 Max: 104.72
Current: 20.16
During the past 13 years, the highest PE Ratio (TTM) of ShareHope Medicine Co was 104.72. The lowest was 8.11. And the median was 20.88.
ROCO:8403's PE Ratio (TTM) is ranked worse than 65.52% of 87
companies
in the Medical Distribution industry
Industry Median: 15.37
vs ROCO:8403: 20.16
During the past 12 months, ShareHope Medicine Co's average EPS without NRIGrowth Rate was -39.60% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was -20.70% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was -9.80% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was -0.80% per year.
During the past 13 years, ShareHope Medicine Co's highest 3-Year average EPS without NRI Growth Rate was 32.80% per year. The lowest was -20.70% per year. And the median was 4.15% per year.
ShareHope Medicine Co's EPS (Basic) for the
three
months ended in Mar. 2026 was NT$0.13.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was NT$0.94.
ShareHope Medicine Co (ROCO:8403) PE Ratio (TTM) Explanation
The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.
If a company loses money, the PE Ratio (TTM) becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.
Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .
PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).
ShareHope Medicine Co PE Ratio (TTM) Related Terms
ShareHope Medicine Co PE Ratio (TTM) Historical Data
* Premium members only.
The historical data trend for ShareHope Medicine Co's PE Ratio (TTM) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:8403 vs MCK, COR, CAH: PE Ratio (TTM) Comparison
For the Medical Distribution subindustry, ShareHope Medicine Co's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ShareHope Medicine Co PE Ratio (TTM) vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, ShareHope Medicine Co's PE Ratio (TTM) distribution charts can be found below:
* The bar in red indicates where ShareHope Medicine Co's PE Ratio (TTM) falls into.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.
ShareHope Medicine Co's Share Price of today is NT$18.95.
ShareHope Medicine Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.94.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
ShareHope Medicine Co (ROCO:8403) has a PE Ratio (TTM) of 20.16 as of Aug. 02, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on ShareHope Medicine Co and its competitors. This is near median its historical median of 20.88. Over the past decade, ShareHope Medicine Co's PE Ratio (TTM) has ranged from 8.11 to 104.72. According to the industry distribution chart, ShareHope Medicine Co ranks #57 out of 87 companies in the Medical Distribution industry, placing it in the top 65.5%.
Is ShareHope Medicine Co's PE Ratio (TTM) too high?
ShareHope Medicine Co's current PE Ratio (TTM) of 20.16 is near median its 10-year median of 20.88. Over the past 10 years, this metric has ranged from a low of 8.11 to a high of 104.72. The Medical Distribution industry median PE Ratio (TTM) is 15.37. ShareHope Medicine Co's value of 20.16 is 31.2% above this industry median. Based on the distribution chart, ShareHope Medicine Co ranks #57 out of 87 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, ShareHope Medicine Co has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ShareHope Medicine Co's PE Ratio (TTM) compare to MCK and COR?
According to the Medical Distribution industry distribution chart, ShareHope Medicine Co ranks #57 out of 87 companies for PE Ratio (TTM). This places ShareHope Medicine Co in the lower half of its industry. The industry median PE Ratio (TTM) is 15.37. ShareHope Medicine Co's value of 20.16 is 31.2% above this benchmark. Historically, ShareHope Medicine Co's own PE Ratio (TTM) has ranged from 8.11 to 104.72 over the past decade. While the company's 10-year median is 20.88 vs. the industry median of 15.37, ShareHope Medicine Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Medical Distribution company?
The median PE Ratio (TTM) among Medical Distribution companies is 15.37, based on 87 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ShareHope Medicine Co's current PE Ratio (TTM) of 20.16 is 31.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on ShareHope Medicine Co and its competitors. For the Medical Distribution industry, the median PE Ratio (TTM) is 15.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ShareHope Medicine Co's current PE Ratio (TTM) is 20.16, which is near median its own 10-year median of 20.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ShareHope Medicine Co stock overvalued right now?
Based on GuruFocus' analysis, ShareHope Medicine Co (ROCO:8403) is currently considered Possible Value Trap. The stock's GF Value™ is NT$29.89, compared to a current price of NT$18.95 — trading 36.6% below its estimated fair value. The current PE Ratio (TTM) is 20.16, which is near median its 10-year median of 20.88 and 31.2% above the Medical Distribution industry median of 15.37. ShareHope Medicine Co's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For ShareHope Medicine Co (ROCO:8403), the current PE Ratio (TTM) is 20.16 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ShareHope Medicine Co (ROCO:8403) Overvalued in 2026?
Based on GuruFocus' analysis, ShareHope Medicine Co stock appears to be undervalued.
The current stock price of NT$18.95 is trading 36.6% below its estimated GF Value™ of NT$29.89.
GuruFocus considers ShareHope Medicine Co to be Possible Value Trap.
Key valuation signals for ROCO:8403:
PE Ratio (TTM): 20.16 (near median its 10-year median of 20.88)
GF Value™: NT$29.89 vs. price of NT$18.95 (36.6% below fair value)
Industry Position: 31.2% above the Medical Distribution median (#57 of 87)
No single metric tells the full story. See the ROCO:8403 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ShareHope Medicine Co Ltd is engaged in wholesale and retail sales of medicines and hygiene materials, leasing of assets for medical institutions to undertake related medical services, and physical examinations for Taiwanese people and foreign labors, on-site medical support services, hemodialysis business management, ophthalmic medical management, clothing-related management services, manufacturing, processing and sales of various non-woven fabrics and management consulting for chain pharmacies in collaboration with medical institutions.
70GF Score
Get the complete analysis for ROCO:8403
PE Ratio (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:8403 has been successfully added to your 
